Rhesus macaque Coagulation factor XI Protein, His Tag (Pro-form)

Customer Reviews
Cat. No. / Size
Price
Qty
FXI-C52H3-50ug
$465.00
FXI-C52H3-500ug
$2680.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    Coagulation factor XI, FXI, PTA, F11

  • Source

    Rhesus macaque Coagulation factor XI Protein, His Tag (FXI-C52H3) is expressed from human 293 cells (HEK293). It contains AA Glu 19 - Ala 624 (Accession # G7MSF8-1).

    Predicted N-terminus: Glu 19

    Request for sequence
  • Molecular Characterization

    Coagulation factor XI Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 69.8 kDa. The protein migrates as 80-90 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 20 mM HEPES,150 mM NaCl,pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Coagulation factor XI SDS-PAGE

    Rhesus macaque Coagulation factor XI Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     Coagulation factor XI ELISA

    Immobilized Rhesus macaque Coagulation factor XI Protein, His Tag (Cat. No. FXI-C52H3) at 1 μg/mL (100 μL/well) can bind Abelacimab with a linear range of 0.03-2 ng/mL (QC tested).

    Protocol
  •  Coagulation factor XI ELISA

    Immobilized Abelacimab at 1 μg/mL (100 μL/well) can bind Rhesus macaque Coagulation factor XI Protein, His Tag (Cat. No. FXI-C52H3) with a linear range of 0.001-0.063 μg/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     Coagulation factor XI SPR

    Abelacimab captured on Protein A Chip can bind Rhesus macaque Coagulation factor XI, His Tag (Cat. No. FXI-C52H3) with an affinity constant of 22.4 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity

    Measured by its ability to cleave the fluorogenic peptide substrate, t­-butyloxycarbonyl-­Ile­-Glu­-Gly-­Arg-­7-­amido-­4-­methylcoumarin (Boc­-IEGR-AMC). The specific activity is >110 pmol/min/µg (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality

Recent Advances

 
Drug Development Progress
  • English Name:

    Coagulation factor XI

  • Category:

  • Approved Drugs:

    2 Details

  • Drugs in Clinical Trials:

    31 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland